Page last updated: 2024-11-02

oxybutynin and Premenstrual Dysphoric Disorder

oxybutynin has been researched along with Premenstrual Dysphoric Disorder in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Premenstrual Dysphoric Disorder: A condition in which a woman suffers from severe depression, irritability, and tension before MENSTRUATION. Premenstrual dysphoric disorder (PMDD) may involve a wide range of physical or emotional symptoms, which are more severe and debilitating than those seen with premenstrual syndrome (PMS), and which include at least one mood-related symptom. Symptoms usually stop when, or shortly after, menstruation begins.

Research Excerpts

ExcerptRelevanceReference
"One study compared patch dosage (100 vs 200 µg oestrogen, with progestogen in both arms) and had a high risk of performance bias, detection bias and attrition bias."2.55Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome. ( Kuiper, JH; Naheed, B; O'Brien, PM; O'Mahony, F; Uthman, OA, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naheed, B1
Kuiper, JH1
Uthman, OA1
O'Mahony, F1
O'Brien, PM1

Reviews

1 review available for oxybutynin and Premenstrual Dysphoric Disorder

ArticleYear
Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
    The Cochrane database of systematic reviews, 2017, Mar-03, Volume: 3

    Topics: Administration, Oral; Drug Implants; Drug Therapy, Combination; Estrogens; Female; Humans; Luteal Ph

2017